CLL is a cancer in which the bone marrow produces too many lymphocytes, white blood cells that play a critical role in the immune system. CLL accounts for 30% of all adult leukemia cases and is the most common form of leukemia in western countries, with an average annual incidence of 5.0 cases per 100,000 population in people of all ages. CLL primarily affects older populations, with less than 10% of cases occurring in people under 40 years of age. Because most CLL progresses slowly and early screening is not recommended, CLL is often diagnosed after routine blood tests.

Multiple staging systems exist to categorize CLL patients by risk for progression. The most commonly used staging system in Europe is the Binet staging system. This staging system classifies patients based on the number of affected lymphoid tissue areas and presence of anemia and thrombocytopenia, with stage C being most advanced and stage A being least advanced.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The higher percentage of patients diagnosed at later stages in the UK suggests poorer outcomes among those diagnosed with CLL compared with other markets. Indeed, the five-year relative survival among CLL patients is lower in the UK (64.47%) than in the rest of the 7MM (67.90–85.08%).

Details about the trend analysis and other discussions of prostate cancer epidemiology can be found in GlobalData’s EpiCast Report: Chronic Lymphocytic Leukemia – Epidemiology Forecast to 2025 and EpiCast Model: Chronic Lymphocytic Leukemia – Epidemiology Forecast to 2025.

Related Reports

GlobalData (2017). EpiCast Report: Chronic Lymphocytic Leukemia – Epidemiology Forecast to 2025, November 2017, GDHCER164-17

GlobalData (2017). EpiCast Model: Chronic Lymphocytic Leukemia – Epidemiology Forecast to 2025, November 2017, GDHCEM164-17

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

GlobalData (2014). Expert Insight: Late-Stage CLL Pipeline Consolidates Under AbbVie’s Umbrella, September 2014, GDHC0758EI